Judit Pich

Academic / Other · 7 registered clinical trials.

Status	Trial	Phase	Started
Withdrawn	Evaluating a Combination of Immune-based Therapies to Achieve a Remission of HIV Infection HIV Infections	Phase 1 / Phase 2	2020-11-01
Active Not Recruiting	Dendritic Cells Therapy Combined With Immunomodulatory Treatment in Multiple Sclerosis Relapsing-Remitting Multiple Sclerosis	Phase 2	2020-01-27
Completed	Efficacy of the Combination of Simvastatin Plus Rifaximin in Patients With Decompensated Cirrhosis to Prevent Liver Cirrhoses	Phase 2 / Phase 3	2019-01-03
Terminated	Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppre HIV Seropositivity, HIV Infections, HIV-1-infection	Phase 3	2018-05-03
Completed	Simplification Study of HIV-1 Infected Patients With Virological Suppression Under the Combination of Lamivudi HIV Infections, HIV-1-infection, HIV Seropositivity	Phase 3	2018-05-02
Completed	Simvastatin Plus Rifaximin in Decompensated Cirrhosis Cirrhoses, Liver	Phase 2	2017-07-26
Completed	Simplification From Tenofovir Plus Lamivudine or Emtricitabine Plus Ritonavir-Boosted-Protease Inhibitor to Ri Human Immunodeficiency Virus	N/A	2015-11-01